Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CEUS and SWE in Neoadjuvant Breast Cancer
NCT02067884Phase 1Terminated
- Sponsor
- University of Southern California
- Start
- Dec 2013
- Primary completion
- Sep 2016
- Countries
- 1
01
Overview
Phase 1, open-label, single-arm trial, sponsored by University of Southern California. Primary endpoints: Model predicted treatment response for CEUS and SWE up to 1 year and Pathologically determined treatment response for CEUS and SWE up to 1 year. Started Dec 2013; status: terminated.
Beyond the preview
Go deeper on NCT02067884.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02067884.